| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
ConivaptanADHSodium (Hyponatriemia)UreaSIADHDemeclocycline| 1 | 2007 | Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected]. | 
| + | - | nl | Cardiovasc Drug Rev 25(3):261-79 (2007) |
| 2 | 2008 | Conivaptan: a step forward in the treatment of hyponatremia? |
| + | - | nl | Ther Clin Risk Manag 4(2):315-26 (2008) |
| 3 | 2010 | Conivaptan: Evidence supporting its therapeutic use in hyponatremia. |
| + | - | nl | Core Evid 4(-):83-92 (2010) |
| 4 | 2009 | Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. | 
| + | - | nl | Liver Transpl 15(10):1325-9 (2009) |
| 5 | 2010 | The syndrome of inappropriate antidiuretic hormone: current and future management options. |
| + | - | nl | Eur J Endocrinol 162 Suppl 1(-):S13-8 (2010) |
| 6 | 2009 | New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia. |
| + | - | nl | J Pharmacol Sci 109(1):53-9 (2009) |
